[The treatment of postpubertal Leydig cell insufficiency with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (Mesterolone)].
D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D000728:Androgens / Q000627:therapeutic use*; D005632:Fructose; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy*; D007985:Leydig Cells / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011627:Puberty; D012661:Semen / Q000032:analysis
D045930:Anabolic Agents; D000728:Androgens; D005632:Fructose
Die Behandlung der postpuberalen Leydig-Zell-Insuffizienz mit 1-alpha-Methyl-5-alpha-androstan-17-beta-ol-3-on (Mesterolon)